Semin Respir Crit Care Med 2002; 23(2): 085-092
DOI: 10.1055/s-2002-25298
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Lymphangioleiomyomatosis

Simon R. Johnson1 , Anne E. Tattersfield2
  • 1Division of Therapeutics, University Hospital, Queens Medical Centre, Nottingham, UK
  • 2City Hospital, Nottingham, UK
Further Information

Publication History

Publication Date:
24 April 2002 (online)

ABSTRACT

Lymphangioleiomyomatosis (LAM) is a rare disease categorized by an overgrowth of atypical smooth muscle cells (LAM cells) in the lungs and axial lymphatics, which is associated with the mesenchymal tumor angiomyolipoma. The disease occurs in women generally in their mid thirties with a prevalence approximately 1 per million in the general population but is much more frequent in women with tuberous sclerosis complex (TSC). LAM is categorized by airflow obstruction, lung cysts, recurrent pneumothorax, and pleural and abdominal chylous collections. The disease is progressive, generally resulting in respiratory failure and death. The TSC-2 gene is abnormal in LAM cells and may be responsible for their disordered growth. These cells are of an unusual phenotype, expressing smooth muscle proteins, melanoma proteins, estrogen and progesterone receptors. Although at present of unknown significance these are useful in diagnosis. Treatment is largely supportive, being directed at airflow obstruction, pneumothorax, chylous complications, and bleeding from angiomyolipomas. In patients with rapidly progressive disease, hormone manipulation is frequently tried in the form of progesterone or antiestrogen therapies although no firm evidence of their efficacy exists.

REFERENCES

  • 1 Johnson S R, Tattersfield A E. Decline in lung function in patients with lymphangioleiomyomatosis: effect of menopause and progesterone treatment.  Am J Respir Crit Care Med . 1999;  160 628-633
  • 2 Urban T, Lazor R, Lacronique M. Pulmonary lymphangioleiomyomatosis: a study of 69 cases.  Medicine . 1999;  78 321-337
  • 3 Costello L C, Hartman T E, Ryu J H. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex.  Mayo Clinic Proceedings . 2000;  75 591-594
  • 4 Corrin B, Liebow A A, Friedman P J. Pulmonary lymphangioleiomyomatosis.  American Journal of Pathology . 1975;  79 348-382
  • 5 Taylor J R, Ryu J, Colby T V, Raffin T A. Lymphangioleiomyomatosis: clinical course in 32 Patients.  N Engl J Med . 1990;  323 1254-1260
  • 6 Johnson S R, Tattersfield A E. Clinical experience of lymphangioleiomyomatosis in the UK.  Thorax . 2000;  55 1052-1057
  • 7 Kitaichi M, Nishimura K, Itoh H, Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors.  Am J Respir Crit Care Med . 1995;  151 527-533
  • 8 Chu S C, Horiba K, Usuki J. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis.  Chest . 1999;  115 1041-1052
  • 9 Bernstein S M, Newell J D, Adamczyk D. How common are renal angiomyolipomas in patients with lymphangioleiomyomatosis?.  Am J Respir and Crit Care Med . 1995;  152 2138-2143
  • 10 Maziak D E, Kesten S, Rappaport D C, Maurer J. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis.  Eur Respir J . 1996;  9 402-405
  • 11 Avila N A, Kelly J A, Chu S C. Lymphangioleiomyomatosis: abdominopelvic CT and US findings.  Radiology . 2000;  216 147-153
  • 12 Matsui K, Tatsuguchi A, Valencia J. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.  Hum Pathol . 2000;  3 1242-1248
  • 13 Avila N A, Chen C C, Chu S C. Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests.  Radiology . 2000;  214 441-446
  • 14 Lazor R, Laque D, Delaval, et al. Predictors of rapid decline of FEV1 in 50 cases of lymphangioleiomyomatosis.  Am J Respir Crit Care Med . 2000;  161 A15
  • 15 Sherrier R H, Chiles C, Roggli V. Pulmonary lymphangioleiomyomatosis CT findings.  Am J Radiol . 1989;  153 937-940
  • 16 Muller N L, Chiles C, Kullnig P. Pulmonary lymphangioleiomyomatosis: correlation of CT with radiographic and functional findings.  Radiology . 1990;  175 335-339
  • 17 Bosniak M A. Angiomyolipoma (hamartoma) of the kidney: a preoperative diagnosis is possible in virtually every case.  Urologic Radiology . 1981;  3 135-142
  • 18 Boelher A, Speich R, Russi E W, Weder W. Lung transplantation for lymphangioleiomyomatosis.  N Engl J Med . 1996;  335 1275-1280
  • 19 Bonetti F, Chiodera P, Pea M. Transbronchial biopsy in lymphangioleiomyomatosis of the lung: HMB45 for diagnosis.  Am J Surg Pathol . 1993;  17 1092-1102
  • 20 Fukuda Y, Kawamoto M, Yamamoto A. Role of elastic fibre degradation in emphysema-like lesions of pulmonary lymphangioleiomyomatosis.  Hum Pathol . 1990;  21 1252-1261
  • 21 Matsui K, Riemenschneider W, Hilbert S L. Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis.  Arch Pathol Lab Med . 2000;  124 1642-1648
  • 22 Lantuejoul S, Ferretti G, Negoescu A. Multifocal alveolar hyperplasia associated with lymphangioleiomyomatosis in tuberous sclerosis.  Histopathology . 1997;  30 570-575
  • 23 Flieder D B, Travis W D. Clear cell ``sugar'' tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis.  Am J Surg Pathol . 1997;  21 1242-1247
  • 24 Yamanaka A, Kitaichi M, Fujimoto T. Multifocal micronodular pneumocyte hyperplasia in a postmenopausal woman with tuberous sclerosis.  Virchows Arch . 2000;  436 389-392
  • 25 Pea M, Bonetti F, Zamboni G. Melanocyte marker HMB-45 is regularly expressed in angiomyolipoma of the kidney.  Pathology . 1991;  23 185-188
  • 26 Logginidou H, Ao X, Russo I, Henske E P. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis.  Chest . 1999;  117 25-30
  • 27 Chan J KC, Tsang W YW, Pau M Y. Lymphangioleiomyomatosis and angiomyolipoma: closely related entities characterised by hamartomatous proliferation of HMB-45 positive smooth muscle.  Histopathology . 1993;  22 445-455
  • 28 Fetsch P A, Fetsch J F, Marincola F M. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor.  Mod Pathol . 1998;  11 699-703
  • 29 Matsumoto Y, Horiba K, Usuki J. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.  Am J Respir Cell Mol Biol . 1999;  21 327-336
  • 30 Brentani M M, Carvalho C RR, Saldiva P H. Steroid receptors in pulmonary lymphangioleiomyomatosis.  Chest . 1984;  85 96-99
  • 31 Matsui K, Takeda K, Yu Z X. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy: an immunohistochemical study.  Am J Respir Cri Care Med . 2000;  161 1002-1009
  • 32 Usuki J, Horiba K, Chu S C. Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status.  Arch Pathol Lab Med . 1998;  122 895-902
  • 33 Hayashi T, Fleming M V, Stetler-Stevenson W G. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).  Hum Pathol . 1997;  28 1071-1078
  • 34 Matsui K, Takeda K, Yu Z X. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.  Arch Pathol Lab Med . 2000;  124 267-275
  • 35 McCawley L J, Matrisian L M. Matrix metalloproteinases: multifunctional contributors to tumor progression.  Molecular Medicine Today . 2000;  6 149-156
  • 36 Astrinidis A L, Khare T, Carsillo, et al. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.  J of Med Genet . 2000;  37 55-57
  • 37 Valensi Q J. Pulmonary lymphangiomyoma: a probable forme fruste of tuberous sclerosis.  Am Rev Respir Dis . 1973;  108 1411-1415
  • 38 Smolarek T A, Wessner L L, McCormack F X. Evidence that lymphangioleiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis Am J Hum Genet .  1998;  62 810-815
  • 39 Carsillo T, Astrinidis A, Henske E P. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.  Proceedings of the National Academy of Sciences of the United States of America . 2000;  97 6085-6090
  • 40 Mahadeva R, Stewart S, Wallwork J. Metastatic endometrial stromal sarcoma masquerading as pulmonary lymphangioleiomyomatosis.  Am J Clin Pathol . 1999;  52 147-148
  • 41 Itoh T, Mochizuki M, Kumazaki S. Cystic pulmonary metastases of endometial stromal sarcoma of the uterus mimicking pulmonary lymphangioleiomyomatosis: a case report with immunohistochemistry of HMB45.  Pathology International . 1997;  47 725-729
  • 42 McCarty K S, Mossler J A, McClelland R, Seiker H O. Pulmonary lymphangioleiomyomatosis responsive to progesterone.  N Engl J Med . 1981;  303 1461-1465
  • 43 Eliasson A H, Phillips Y Y, Tenholder M F. Treatment of lymphangioleiomyomatosis: a meta-analysis.  Chest . 1989;  196 1352-1355
  • 44 Tomasian A, Greenberg M S, Rumerman H. Tamoxifen for lymphangioleiomyomatosis [letter].  N Engl J Med . 1982;  306 745-746
  • 45 Warren S E, Lee D, Martin V, Messin W. Pulmonary lymphangiomyomatosis causing bilateral pneumothorax during pregnancy.  Ann Thorac Surg . 1993;  55 998-1000
  • 46 Hughes E, Hodder R V. Pulmonary lymphangiomyomatosis complicating pregnancy: a case report.  J Reprod Med . 1987;  32 553-557
  • 47 Calvo E, Amarillas L, Mateos M A. Lymphangioleiomyomatosis chylous ascites and diet.  Dig Dis Sci . 1996;  41 591-593
  • 48 Steiner M S, Goldman S M, Fishman E K, Marshall F F. The natural history of renal angiomyolipoma.  J Urol . 1993;  150 1782-1786
  • 49 Kennelly M J, Grossman H B, Cho K J. Outcome and analysis of 42 cases of renal angiomyolipoma.  J Urol . 1994;  152 1988-1991
  • 50 Han Y M, Kim J K, Roh B S. Renal angiomyolipoma: selective arterial embolization-effectiveness and changes in angiomyogenic components in long-term follow-up.  Radiology . 1997;  204 65-70
  • 51 Fazeli-Matin S, Novick A C. Nephron-sparing surgery for renal angiomyolipoma.  Urology . 1998;  52 577-583
  • 52 Trulock E P. Lung transplantation: special considerations and outcome in LAM. In: Moss J, ed. LAM and Other Diseases Characterized by Smooth Muscle Proliferation. New York: Marcel Dekker 1999: 65-78
  • 53 O'Brien J D, Lium J H, Parosa J F. Lymphangioleiomyomatosis recurrence in the allograft after single lung transplantation.  Am J Respir Crit Care Med . 1995;  151 2033-2036
  • 54 Bittman I, Dose T B, Muller C. Lymphangioleiomyomatosis: recurrence after single lung transplantation.  Hum Pathol . 1997;  28 1420-1423
  • 55 Nine J S, Yousem S A, Paradis I L. Lymphangioleiomyomatosis: recurrence after lung transplantation.  J Heart Lung Transplant . 1994;  13 714-719